Daniel Klamer

Company: Anavex

Job title: Vice President of Business Development & Scientific Strategy

Seminars:

Fireside Chat: Adopting an Integrated Approach to Measuring Mitochondrial Activity for Validating Biomarkers 9:30 am

Determining disease-specific biomarkers that can accurately reflect disease progression over time Formulating a shared mechanism to identify biomarkers that can be reliably and non-invasively measured for application across disease indications Interrogating organelle cross-talk to explore non-traditional avenues for biomarker validationRead more

day: CONFERENCE DAY TWO

Uncovering Mitochondrial & Related Pathways for Parkinson’s Disease & Dementia to Discover Biomarkers 9:00 am

Analyzing various methods to discover pharmacodynamic biomarkers for Parkinson’s disease and dementia Identifying specific pathways that could outperform standard markers to overcome the transient nature of metabolic products Leveraging the genetic linkage of Parkinson’s disease and dementia with mitochondrial dysfunction to potentially trace back to the root cause of pathogenesisRead more

day: CONFERENCE DAY TWO